EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Contemporary Review of Adenocarcinoma of the Cervix

N Desravines, C Tran, S Wethington, M Y Williams-Brown

Current Treatment Options in Oncology · 2024-12 · 25 (12) · 1538-1549

DOI: 10.1007/s11864-024-01254-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, online erschienen am 13.11.2024. Verfasst von N Desravines und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Women's Health, University of Texas at Austin Dell Medical School, Austin, TX, USA. nerlyne.desravine…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 94 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OPINION STATEMENT: Among cervical cancers, adenocarcinoma is less common than squamous cell carcinoma of the cervix; however, the incidence of these cancers is rising. The incidence has changed largely due to a shift in risk factors as well as the evolution of the diagnosis and classification of adenocarcinoma. Adenocarcinoma of the cervix is composed of a diverse group of neoplasms that can be classified by various factors. In this review article, preinvasive disease, updated classifications of adenocarcinoma, and treatment options for cervical adenocarcinoma are discussed with a focus on current and future therapies. Advances in antibody-drug conjugates (ADC) and immunotherapy have increased the treatment options available for usual-type adenocarcinoma but there is still a lack of variety of treatment options for the remaining 25% of non-usual-type adenocarcinomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsAdenocarcinomaHumansFemaleDisease ManagementCombined Modality TherapyNeoplasm StagingImmunotherapyImmunoconjugatesTreatment Outcome

Stichwörter der Autor:innen

Adenocarcinoma of cervixAdenocarcinoma of uteri cervixCarcinoma of cervixEndocervical adenocarcinomaMalignant cervical neoplasmMalignant neoplasm of uteri cervix

Substanzen

Immunoconjugates

Autor:innen und Institutionen

  • Division of Gynecologic Oncology, Department of Women's Health, University of Texas at Austin Dell Medical School, Austin, TX, USA. nerlyne.desravines@austin.utexas.edu.
  • Department of Women's Health, University of Texas at Austin Dell Medical School, Austin, TX, USA.
  • Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Division of Gynecologic Oncology, Department of Women's Health, University of Texas at Austin Dell Medical School, Austin, TX, USA.

Zitieren

APA

Desravines, N., Tran, C., Wethington, S., & Williams-Brown, M. Y. (2024). Contemporary Review of Adenocarcinoma of the Cervix. Current Treatment Options in Oncology, 25(12), 1538-1549. https://doi.org/10.1007/s11864-024-01254-9

Vancouver

Desravines N, Tran C, Wethington S, Williams-Brown MY. Contemporary Review of Adenocarcinoma of the Cervix. Current Treatment Options in Oncology. 2024;25(12):1538-1549. doi:10.1007/s11864-024-01254-9

BibTeX
@article{Desravines2024,
  author = {Desravines, N and Tran, C and Wethington, S and Williams-Brown, M Y},
  title = {Contemporary Review of Adenocarcinoma of the Cervix},
  journal = {Current Treatment Options in Oncology},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {1538--1549},
  doi = {10.1007/s11864-024-01254-9}
}
Kostenlos starten →